Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Abidat Kachmasova
Observed names:
A. K. Kachmasova,
A. K. Kachmazova,
A. Kachmasova,
Abidat K. Kachmasova
Institutions:
Russian Cancer Research Center NN Blokhin,
Ministry of Health of the Russian Federation,
City Clinical Hospital
Observed institutions:
Russian Cancer Research Center NN Blokhin,
Ministry of Health of the Russian Federation,
City Clinical Hospital
ORCID:
0009-0005-2365-495X
Observed ORCID:
0009-0005-2365-495X
OpenAlex ID:
A5116050913
Phase II study of mFOLFIRINOX efficacy as first and subsequent lines of advanced gastrointestinal neuroendocrine tumors G3 and neuroendocrine carcinomas therapy.
2025
·
Yaroslav Zhulikov
, Ekaterina Evdokimova
, et al.
·
Journal of Clinical Oncology
·
1
PDF
280P Phase II mFOLFIRINOX for advanced gastroenteropancreatic NET G3 and NEC, final results
2026
·
Y.A. Zhulikov
, E.V. Evdokimova
, et al.
·
Annals of Oncology
PDF
Efficacy of mFOLFIRINOX chemotherapy for treatment of high-grade G3 neuroendocrine tumors and gastroenteropancreatic neuroendocrine carcinomas
2026
·
Abidat K. Kachmasova
, Ya. A. Zhulikov
, et al.
·
Surgery and Oncology
Retrospective non-comparative single-center study of platinum-based regimen efficacy in the 1st line therapy of high-grade neuroendocrine carcinomas of gynecologic tract
2026
·
Khadizhat A. Suleymanova
, Ya. A. Zhulikov
, et al.
·
Surgery and Oncology
Efficacy of adjuvant therapy with somatostatin analogues in recurrent type I gastric neuroendocrine tumors
2025
·
K. R. Gadzhieva
, Yа. A. Zhulikov
, et al.
·
Medical alphabet
Show more works
View as search
Works count:
5
Citation count:
1
H-index:
1
I10-index:
Year
Topic
Type